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ABSTRACT
10 The RCSB Protein Data Bank (PDB) offers online
tools, summary reports and target information
related to the worldwide structural genomics initia-
tives from its portal at http://sg.pdb.org. There are
currently three components to this site: Structural
15 Genomics Initiatives contains information and links
on each structural genomics site, including progress
reports, target lists, target status, targets in the PDB
and level of sequence redundancy; Targets provides
combined target information, protocols and other
20 data associated with protein structure determi-
nation; and Structures offers an assessment of
the progress of structural genomics based on the
functional coverage of the human genome by PDB
structures, structural genomics targets and homo-
25 logy models. Functional coverage can be examined
according to enzyme classification, gene ontology
(biological process, cell component and molecular
function) and disease.
INTRODUCTION
30 The wwPDB (1) maintains the Protein Data Bank (PDB)
archives of biological macromolecular structure data, cur-
rently comprising over 32500 structures. Since the year
2000, the worldwide structural genomics initiatives have pro-
vided more than 2400 structures, which have also added a
35 large number of new folds. To represent the progress of
this collective effort, the RCSB PDB (2) has developed
and maintains the Structural Genomics Information Portal
at http://sg.pdb.org which consists of three main sections,
outlined below.
40 Structural genomics initiatives
The ﬁrst section of the information portal provides summary
information about each structural genomics center, including
target lists, target status, targets in the PDB and sequence
redundancy analyses. Summary statistics describing the over-
45 all progress of all contributing projects, including sequence
similarity and number of structures determined, are regularly
tabulated. As an example, an analysis of the sequence simi-
larity of structures solved by structural genomics projects rel-
ative to structures in the PDB archive is shown in Figure 1.
50 Targets
The Targets section offers databases that track target registra-
tion data. Currently, 20 structural genomics centers contribute
data to the TargetDB (3) resource (http://targetdb.pdb.org).
These data include contributing project and target identiﬁer;
55 protein name, source organism and sequence; current produc-
tion status (e.g. cloned, expressed and crystallized); related
database references; and links to related project information.
TargetDB assembles data from all contributing centers and
makes these data available in a single validated XML data
60 ﬁle which is updated weekly.
Targets can also be selected by searching TargetDB by
target identiﬁer, similar sequence, program or project, current
production status, protein name or source organism. Search
results can be captured in FASTA, TargetDB XML or HTML
65 formats. The HTML report presents all of the contributed
details about each target including links to related project
information and archival databases [e.g. sequence, PDB and
BMRB (4)], and links out to protein domain databases. An
additional online form constructs cumulative reports summa-
70 rizing the status of a particular program or project.
Created as an extension to TargetDB, the Protein Expres-
sion Cloning and Puriﬁcation Database, PepcDB (http://
pepcdb.pdb.org), was established to collect more detailed
status information and the experimental details of each step
*To whom correspondence should be addressed. Tel: +1 732 445 4667; Fax: +1 732 445 4320; Email: berman@rcsb.rutgers.edu
  The Author 2006. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
areattributedastheoriginalplaceofpublicationwiththecorrectcitationdetailsgiven;ifanarticleissubsequentlyreproducedordisseminatednotinitsentiretybut
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
D302–D305 Nucleic Acids Research, 2006, Vol. 34, Database issue
doi:10.1093/nar/gkj120in the protein production pipeline. PepcDB captures a com-
plete history of the experimental steps in each production trial,
in addition to describing the current target production status.
The status history in PepcDB also records the time interval
5 required to complete each experimental step, with an explana-
tion if work on a particular target or experiment was termi-
nated. Standardprotocol descriptions are collectedintext form
for each step of protein production. Multiple experimental
trials can be described for each target. Each trial may reference
10 a set of standard protocols and optionally include the special
details of an experimental step and the experimentally
observed sequence.
A validation server has been provided for PepcDB con-
tributors (http://pepcdb.pdb.org/validation.html). Data ﬁles
15 validated through this form are automatically loaded into
the PepcDB database. PepcDB currently includes protocol
information from the NIH Protein Structure Initiative (PSI)
centers. TargetDB status data from all other structural geno-
mics centers are merged into PepcDB. As a result, PepcDB
20 always provides the most complete view of target status and
experimental information for structural genomics projects.
The search features of PepcDB build upon those of
TargetDB by offering additional tools to mine experimental
protocols. Protocol searches are integrated with queries for
25 target sequence and other target attributes. The resulting report
includes the essential target description provided by TargetDB
plus additional links to a chronological status history and links
to related experimental protocols.
Structures
30 The Structures section of the RCSB PDB Structural Geno-
mics Information Portal (http://function.rcsb.org:8080/pdb/
function_distribution/index.html) provides information about
the functional distribution of solved structures, structures
being determined by structural genomics and homology
35 models determined from solved structures (5). Function is
measured relative to Ensembl-assigned functions from the
human genome (6) and disease relative to OMIM assignments
for human diseases (7). This section answers the question
‘With respect to the function of proteins identiﬁed in humans
40 and human disease, what does the present complement of
structures in the PDB, the structural genomics targets (if all
were solved) and homology models that can be built from the
current set of templates add to our understanding of living
systems?’ The answer to this question changes over time,
45 and the functional distribution resource provides a current
answer since the constituent components needed to address
the question—PDB structures, structural genomics targets,
homology models from SUPERFAMILY (8), functional
assignments from Ensembl and disease classiﬁcations from
50 OMIM—are all updated as they change, ranging from weekly
for PDB structures and targets to approximately annually for
SUPERFAMILY. The answer to the question also depends
on the deﬁnition of a homology model. Here the structural
templates used in homology modeling were a set of hidden
55 Markov models taken from SUPERFAMILY 1.65. The
sequences were aligned to the structural template with
HMMER (9). Only those assigned domains with sequence
identity >30% in the alignment were considered as homology
models.
60 Through the functional distribution site, this question can
be addressed by examining molecular function, biological
process and cellular component [as assigned by the Gene
Ontology, GO (10)], enzymes via their EC numbers (www.
chem.qmw.ac.uk/iubmb/enzyme), and diseases assigned
65 through OMIM (7). Several steps are used to deﬁne the search
parameters; here molecular function is used as an example.
Figure 1. August 2005 report from the structural genomics information portal showing structural genomics structures with sequence similarity <30% relative to
solved structures in the PDB by year. Sequence comparisons are performed using the blastclust application (7).
Nucleic Acids Research, 2006, Vol. 34, Database issue D303In Step 1 (Molecular Function) the breadth of the search is
deﬁned, which in turn deﬁnes the details presented in the
results. So, for example, the top level of the GO hierarchy
for molecular function is displayed and used by default. All
5 structures could be selected, or a subgroup could be selected
(e.g. all structures with the molecular function ‘vitamin bind-
ing’) by browsing through the hierarchical tree. Similarly in
Step 2 (Structure Type), all structures are chosen by default,
but it is possible to drill down and explore just groups of
10 structures based on the SCOP classiﬁcation of class (all
alpha, all beta, etc.) (11). Step 3 selects the genome. At present
only the human genome is available, but other model organ-
isms will be added. Step 4 selects the sequence identity to use,
with 40% identity the default. Sequence identity deﬁnes
15 how the human genome sequences are clustered and a single
function assigned for that cluster—at lower sequence identity
there are fewer clusters, i.e. the results are effectively at lower
resolution. Step 5 speciﬁes the domain combinations needed
for a match. Since PDB structures frequently represent a
20 single domain in a larger complex, statistics can be produced
requiring overlap for one or more domains up to the whole
structure accounting for domain rearrangements [see (5) for
a full description].
Based on these input parameters, one of three distributions
25 can be generated: a comparison of the distribution of
PDB structures, structure genomics targets or homology
models against the human genome; a ‘most wanted list’
Table 1. Genome coverage
Function
coverage
Cluster
coverage
Genome sequences 1.000 1.000
PDB structures 0.372 0.094
SG targets 0.324 0.156
Homology models 0.563 0.283
PDB structures + SG tragets 0.515 0.239
PDB structures + homology models 0.595 0.303
SG targets + homology models 0.663 0.411
PDB structures + SG targets + homology models 0.687 0.428
Data are based upon 10801 functionally described human genome sequences
from Ensembl, 942 PDB structures from human, 1680 structural genomics
targets identified in human and 2823 homologymodels from SUPERFAMILY
mapped on to the human genome. Cluster Coverage is the ratio of number of
protein clusters that are structurally covered versus all clusters in the genome
for a functional class with a specified sequence identity (40% in this case).
Functional class and sequence identity are input parameters.
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Figure 2. Normalizedfunctionalcoverageofthehumangenomebysequence(fromEnsembl;red),bystructuresfromthePDB(blue),bystructuralgenomicstargets
(green) and homology models from SUPERFAMILY (yellow). When viewing the figure from the online structural genomics portal, clicking on the appropriate
bar of the histogram will produce a list of sequences or structures that define the distribution.
D304 Nucleic Acids Research, 2006, Vol. 34, Database issueof structures—those not in the PDB and which (by default) are
not identiﬁed through homology modeling or in the structural
genomics targets yet have signiﬁcant presence in the human
genome; and simple charts showing the distribution of the
5 genome sequences, PDB structures, structural genomics tar-
gets or homology models. Most distributions are accompanied
by two tables illustrating, ﬁrst, the functional coverage by each
data type (Table 1), and second, the correlation between input
data types (data not shown). The actual overlap between these
10 groups will be added as part of an on-going development. For
example in Table 1, PDB structures cover 37.2% of the iden-
tiﬁed molecular functions in the human genome; if solved,
structural genomics targets cover 32.4% of functions; and
56.3% of the molecular functions can be modeled from exist-
15 ing structures. Figure 2 illustrates the resulting normalized
distributions for the top level of the GO molecular function
hierarchy. At this level most distributions are not skewed with
the exception of molecular function unknown—PDB struc-
tures are underrepresented and structural genomics targets
20 are overrepresented. Not surprising, since until structural
genomics began structural biology was dominated by deter-
mining structures of known function. In the era of structural
genomics, that trend has reversed. Drilling down to more
detailed descriptions of molecular function (data not shown)
25 reveals a more uneven distribution and suggests changes in
structure determination strategies.
An important feature of this resource is the ‘most wanted
list’ of structures based on the following criteria: (i) functional
categories where proteins are underrepresented by structures;
30 (ii) from (i), proteins which can not be modeled, i.e. proteins
from the human genome without SUPERFAMILY assign-
ments; (iii) if the protein can be associated with a human
disease; and (iv) proteins identiﬁed as likely to be intractable,
i.e. with a transmembrane segment ﬁltered out.
35 CONCLUSION
In this report, we present the resources currently made avail-
able through the RCSB PDB in support of the structural
genomics effort. It is expected that further functionality will
be added as the second phase of the PSI and other worldwide
40 efforts move forward.
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